CR9991A - Nuevo derivado de pleuromutilina y su uso - Google Patents

Nuevo derivado de pleuromutilina y su uso

Info

Publication number
CR9991A
CR9991A CR9991A CR9991A CR9991A CR 9991 A CR9991 A CR 9991A CR 9991 A CR9991 A CR 9991A CR 9991 A CR9991 A CR 9991A CR 9991 A CR9991 A CR 9991A
Authority
CR
Costa Rica
Prior art keywords
compound
skin
pleuromutiline
derivative
new
Prior art date
Application number
CR9991A
Other languages
English (en)
Inventor
H Igo David
A Norton Beth
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CR9991A publication Critical patent/CR9991A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención está dirigida a la sal de L-tartrato del trans-3- aminociclobutil imidodicarbonato de (1S,2R,3S,4S,6R,7R,8R,14R)-4-etenil-3-hidroxi-2,4,7,14-tetrametil-9-oxotriciclo [5.4.3.01,8]tetradec-6-ilo (Compuesto IA): el Compuesto IA es útil para el tratamiento de una variedad de enfermedades y condiciones, tales como infecciones del tracto respiratorio y la piel y estructura de la piel; en consecuencia, la invención está dirigida adicionalmente a composiciones farmacéuticas que comprenden el Compuesto IA: la invención está dirigida aún además a métodos para tratar infecciones del tracto respiratorio y la piel y estructura de la piel utilizando el Compuesto IA o una composición framacéutica que comprende el Compuesto IA.
CR9991A 2005-11-18 2008-05-20 Nuevo derivado de pleuromutilina y su uso CR9991A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73830805P 2005-11-18 2005-11-18

Publications (1)

Publication Number Publication Date
CR9991A true CR9991A (es) 2008-07-29

Family

ID=38068017

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9991A CR9991A (es) 2005-11-18 2008-05-20 Nuevo derivado de pleuromutilina y su uso

Country Status (14)

Country Link
US (1) US20080269342A1 (es)
EP (1) EP1951671A4 (es)
JP (1) JP2009516704A (es)
KR (1) KR20080080125A (es)
CN (1) CN101360712A (es)
AR (1) AR058197A1 (es)
AU (1) AU2006318238A1 (es)
BR (1) BRPI0618775A2 (es)
CA (1) CA2630254A1 (es)
CR (1) CR9991A (es)
EA (1) EA200801364A1 (es)
MA (1) MA29950B1 (es)
TW (1) TW200736203A (es)
WO (1) WO2007062333A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101904565B1 (ko) * 2011-03-08 2018-10-04 지이 헬쓰케어 리미티드 1-아미노-3-히드록시-시클로부탄-1-카르복실산 유도체의 제조
CN102813629A (zh) * 2012-08-29 2012-12-12 湖北龙翔药业有限公司 一种酒石酸沃尼妙林预混剂的制备方法
CN103641702B (zh) * 2013-11-18 2015-11-18 宁夏泰瑞制药股份有限公司 一种截短侧耳素的水解方法
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
WO2018152408A1 (en) * 2017-02-17 2018-08-23 University Of Tennessee Research Foundation Pleuromutilin derivatives and uses thereof
CN111662220A (zh) * 2020-04-20 2020-09-15 常州安蒂卫生物科技有限公司 用于治疗新型冠状病毒肺炎继发细菌感染性疾病的截短侧耳素类化合物
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1182449A1 (en) * 2000-08-21 2002-02-27 Motorola, Inc. Apparatus and method for managing an integrated circuit
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US6750064B2 (en) * 2000-12-28 2004-06-15 S.S.C.I. Inc. Methods of screening for possible solid forms

Also Published As

Publication number Publication date
CA2630254A1 (en) 2007-05-31
AR058197A1 (es) 2008-01-23
EP1951671A2 (en) 2008-08-06
CN101360712A (zh) 2009-02-04
WO2007062333A2 (en) 2007-05-31
MA29950B1 (fr) 2008-11-03
EA200801364A1 (ru) 2009-02-27
WO2007062333A3 (en) 2007-11-08
BRPI0618775A2 (pt) 2011-09-13
AU2006318238A1 (en) 2007-05-31
EP1951671A4 (en) 2010-06-09
US20080269342A1 (en) 2008-10-30
KR20080080125A (ko) 2008-09-02
JP2009516704A (ja) 2009-04-23
TW200736203A (en) 2007-10-01

Similar Documents

Publication Publication Date Title
UY32302A (es) Carboxamidas heterobicíclicas como inhibidoras de cinasas
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
ECSP077324A (es) Amidas bicíclicas como inhibidores de cinasa
BR112012012529A2 (pt) composto indol e seu uso farmacêutico
CR9991A (es) Nuevo derivado de pleuromutilina y su uso
CL2008003326A1 (es) Compuestos derivados de [(2r)-3-[2-(5-fluoro-4-pirimidinil)hidrazino]-3-oxopropil]hidroxiformamida, formas polimorficas 1, 2 y 3 de dichos compuestos; composicion farmaceutica; y su uso en el tratamiento de una enfermedad bacteriana del oido, sinusitis, infeccion del tracto respiratorio superior, entre otras.
MX2011009847A (es) Agentes antihelminticos y su uso.
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
BR112014006297A2 (pt) inibidores de n-[1-ciano-2-(fenil) etil]-2-azabiciclo [2.2.1] heptano-3-carboxamida de catepsina c, seus usos, e composição farmacêutica
UY30762A1 (es) Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
WO2011006935A3 (en) Tetrazole derivatives
MX2011013869A (es) Agentes antihelminticos y su uso.
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
CR10524A (es) Compuesto triciclico y uso farmaceutico del mismo
ATE427315T1 (de) Neue makrolide
MX2010008690A (es) Farmacoforos duales - antagonistas muscarinicos de pde4.
TW200738599A (en) New pleuromutilin derivative and its use
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
CL2007003318A1 (es) Compuestos derivados de 4,5-difenil-pirrol-2-carboxamida; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento o la prevencion de enfermedades tales como sindrome de abstinencia a una sustancia, t
BR112012015170A2 (pt) "derivado de amino-heteroarila, composição farmacêutica, uso de um derivado de amino-heteroarila, e, método para tratamento de dor."
EA201390345A1 (ru) Терапевтическое болеутоляющее средство
EP2073635A4 (en) MACROCYCLIC SPIROPIPERIDINE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)